US Stock MarketDetailed Quotes

MYGN Myriad Genetics

Watchlist

13.660
+0.030+0.22%

Trading Dec 31 11:28 ET

1.24BMarket Cap-10.67P/E (TTM)

Myriad Genetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

103.17%700K

388.89%2.6M

43.98%-18.6M

-4.33%-110.9M

-649.32%-54.7M

-689.29%-22.1M

98.19%-900K

28.60%-33.2M

-671.51%-106.3M

23.16%-7.3M

Net income from continuing operations

63.95%-22.1M

68.39%-36.7M

52.47%-26M

-135.09%-263.3M

26.24%-31.2M

-74.64%-61.3M

-723.40%-116.1M

-166.83%-54.7M

-311.76%-112M

-456.58%-42.3M

Operating gains losses

----

---2.2M

--1.5M

--0

--100K

----

Depreciation and amortization

10.64%15.6M

13.53%15.1M

-19.07%15.7M

17.46%61.9M

10.22%15.1M

7.63%14.1M

3.10%13.3M

49.23%19.4M

-16.08%52.7M

3.01%13.7M

Deferred tax

-120.00%-1.1M

-375.00%-1.9M

-40.00%1.2M

98.12%-600K

83.00%-1.7M

95.50%-500K

92.16%-400K

135.09%2M

8.07%-31.9M

-19.05%-10M

Other non cash items

-87.75%2.5M

108.51%800K

-99.41%100K

63.43%21.9M

3.23%-6M

51.11%20.4M

-435.71%-9.4M

412.12%16.9M

-35.58%13.4M

-293.75%-6.2M

Change In working capital

-12.31%-7.3M

-102.32%-2.3M

15.23%-20.6M

132.34%27M

-278.79%-41.3M

-187.84%-6.5M

275.09%99.1M

57.67%-24.3M

-169.12%-83.5M

226.92%23.1M

-Change in receivables

-127.78%-8.2M

-108.11%-600K

77.71%-3.9M

-50.65%3.8M

-14.63%17.5M

-159.02%-3.6M

188.10%7.4M

-66.67%-17.5M

187.50%7.7M

583.33%20.5M

-Change in inventory

--0

-416.67%-3.1M

-5.88%-1.8M

37.93%-1.8M

113.33%3.2M

37.21%-2.7M

-700.00%-600K

-750.00%-1.7M

-281.25%-2.9M

-53.13%1.5M

-Change in prepaid assets

20.00%-1.2M

-20.51%3.1M

-65.00%-6.6M

-60.87%900K

78.57%2.5M

-200.00%-1.5M

-18.75%3.9M

-17.65%-4M

-97.24%2.3M

107.78%1.4M

-Change in payables and accrued expense

-76.38%3M

-102.80%-2.1M

-881.82%-8.6M

127.98%23.7M

-32,450.00%-65.1M

92.42%12.7M

242.59%75M

102.86%1.1M

-213.08%-84.7M

0.00%-200K

-Change in other current assets

-118.37%-900K

117.86%500K

108.70%200K

166.67%600K

--800K

1,080.00%4.9M

-2,700.00%-2.8M

-666.67%-2.3M

75.00%-900K

--0

-Change in other working capital

----

0.00%100K

96.00%-200K

----

4,150.00%16.2M

102.22%100K

81.20%-5M

98.39%-100K

Cash from discontinued investing activities

Operating cash flow

103.17%700K

388.89%2.6M

43.98%-18.6M

-4.33%-110.9M

-649.32%-54.7M

-689.29%-22.1M

98.19%-900K

28.60%-33.2M

-671.51%-106.3M

23.16%-7.3M

Investing cash flow

Cash flow from continuing investing activities

400.00%7.5M

-154.24%-6.4M

-120.52%-7.1M

141.16%31.9M

66.29%-12M

-121.93%-2.5M

198.33%11.8M

183.78%34.6M

-128.24%-77.5M

-37.45%-35.6M

Capital expenditure reported

64.00%-6.3M

52.66%-8.9M

63.40%-8.6M

-61.81%-73.3M

7.53%-13.5M

1.13%-17.5M

-180.60%-18.8M

-273.02%-23.5M

-151.67%-45.3M

-329.41%-14.6M

Net business purchase and sale

----

--0

----

-115.09%-57.2M

----

Net investment purchase and sale

-66.67%5M

-91.83%2.5M

-97.42%1.5M

320.80%105.2M

-95.86%1.5M

-48.45%15M

677.36%30.6M

266.00%58.1M

128.84%25M

260.89%36.2M

Cash from discontinued investing activities

Investing cash flow

400.00%7.5M

-154.24%-6.4M

-120.52%-7.1M

141.16%31.9M

66.29%-12M

-121.93%-2.5M

198.33%11.8M

183.78%34.6M

-128.24%-77.5M

-37.45%-35.6M

Financing cash flow

Cash flow from continuing financing activities

-24.00%-3.1M

-93.75%2.4M

-79.59%-8.8M

2,011.25%152.9M

5,904.76%121.9M

30.56%-2.5M

1,436.00%38.4M

-2.08%-4.9M

94.69%-8M

-90.91%-2.1M

Net issuance payments of debt

0.00%-100K

-100.25%-100K

---100K

--39.8M

---100K

--40M

--0

Net common stock issuance

----

--117.6M

----

--0

----

Proceeds from stock option exercised by employees

--0

----

-4.76%6M

150.00%6M

--0

----

-93.14%6.3M

33.33%2.4M

Net other financing activities

-25.00%-3M

68.75%-500K

-77.55%-8.7M

26.57%-10.5M

64.44%-1.6M

46.67%-2.4M

-700.00%-1.6M

3.92%-4.9M

10.63%-14.3M

-55.17%-4.5M

Cash from discontinued financing activities

Financing cash flow

-24.00%-3.1M

-93.75%2.4M

-79.59%-8.8M

2,011.25%152.9M

5,904.76%121.9M

30.56%-2.5M

1,436.00%38.4M

-2.08%-4.9M

94.69%-8M

-90.91%-2.1M

Net cash flow

Beginning cash position

-10.20%101.2M

67.35%105.6M

112.20%140.9M

-74.34%66.4M

-23.22%85M

6.12%112.7M

-61.90%63.1M

-74.34%66.4M

121.20%258.8M

-62.50%110.7M

Current changes in cash

127.31%7.4M

-107.51%-3.7M

-885.71%-34.5M

138.53%73.9M

222.67%55.2M

-642.00%-27.1M

183.28%49.3M

96.22%-3.5M

-234.69%-191.8M

-23.29%-45M

Effect of exchange rate changes

300.00%1.2M

-333.33%-700K

-500.00%-800K

200.00%600K

0.00%700K

-20.00%-600K

250.00%300K

133.33%200K

0.00%-600K

600.00%700K

End cash Position

29.18%109.8M

-10.20%101.2M

67.35%105.6M

112.20%140.9M

-23.22%85M

6.12%112.7M

-61.90%63.1M

-74.34%66.4M

Free cash flow

85.86%-5.6M

68.02%-6.3M

52.03%-27.2M

-21.50%-184.2M

-211.42%-68.2M

-93.17%-39.6M

65.07%-19.7M

-7.39%-56.7M

-25,366.67%-151.6M

-69.77%-21.9M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	103.17%700K	388.89%2.6M	43.98%-18.6M	-4.33%-110.9M	-649.32%-54.7M	-689.29%-22.1M	98.19%-900K	28.60%-33.2M	-671.51%-106.3M	23.16%-7.3M
Net income from continuing operations	63.95%-22.1M	68.39%-36.7M	52.47%-26M	-135.09%-263.3M	26.24%-31.2M	-74.64%-61.3M	-723.40%-116.1M	-166.83%-54.7M	-311.76%-112M	-456.58%-42.3M
Operating gains losses	----	----	---2.2M	--1.5M	--0	--100K	----	----	----	----
Depreciation and amortization	10.64%15.6M	13.53%15.1M	-19.07%15.7M	17.46%61.9M	10.22%15.1M	7.63%14.1M	3.10%13.3M	49.23%19.4M	-16.08%52.7M	3.01%13.7M
Deferred tax	-120.00%-1.1M	-375.00%-1.9M	-40.00%1.2M	98.12%-600K	83.00%-1.7M	95.50%-500K	92.16%-400K	135.09%2M	8.07%-31.9M	-19.05%-10M
Other non cash items	-87.75%2.5M	108.51%800K	-99.41%100K	63.43%21.9M	3.23%-6M	51.11%20.4M	-435.71%-9.4M	412.12%16.9M	-35.58%13.4M	-293.75%-6.2M
Change In working capital	-12.31%-7.3M	-102.32%-2.3M	15.23%-20.6M	132.34%27M	-278.79%-41.3M	-187.84%-6.5M	275.09%99.1M	57.67%-24.3M	-169.12%-83.5M	226.92%23.1M
-Change in receivables	-127.78%-8.2M	-108.11%-600K	77.71%-3.9M	-50.65%3.8M	-14.63%17.5M	-159.02%-3.6M	188.10%7.4M	-66.67%-17.5M	187.50%7.7M	583.33%20.5M
-Change in inventory	--0	-416.67%-3.1M	-5.88%-1.8M	37.93%-1.8M	113.33%3.2M	37.21%-2.7M	-700.00%-600K	-750.00%-1.7M	-281.25%-2.9M	-53.13%1.5M
-Change in prepaid assets	20.00%-1.2M	-20.51%3.1M	-65.00%-6.6M	-60.87%900K	78.57%2.5M	-200.00%-1.5M	-18.75%3.9M	-17.65%-4M	-97.24%2.3M	107.78%1.4M
-Change in payables and accrued expense	-76.38%3M	-102.80%-2.1M	-881.82%-8.6M	127.98%23.7M	-32,450.00%-65.1M	92.42%12.7M	242.59%75M	102.86%1.1M	-213.08%-84.7M	0.00%-200K
-Change in other current assets	-118.37%-900K	117.86%500K	108.70%200K	166.67%600K	--800K	1,080.00%4.9M	-2,700.00%-2.8M	-666.67%-2.3M	75.00%-900K	--0
-Change in other working capital	----	----	0.00%100K	96.00%-200K	----	----	4,150.00%16.2M	102.22%100K	81.20%-5M	98.39%-100K
Cash from discontinued investing activities
Operating cash flow	103.17%700K	388.89%2.6M	43.98%-18.6M	-4.33%-110.9M	-649.32%-54.7M	-689.29%-22.1M	98.19%-900K	28.60%-33.2M	-671.51%-106.3M	23.16%-7.3M
Investing cash flow
Cash flow from continuing investing activities	400.00%7.5M	-154.24%-6.4M	-120.52%-7.1M	141.16%31.9M	66.29%-12M	-121.93%-2.5M	198.33%11.8M	183.78%34.6M	-128.24%-77.5M	-37.45%-35.6M
Capital expenditure reported	64.00%-6.3M	52.66%-8.9M	63.40%-8.6M	-61.81%-73.3M	7.53%-13.5M	1.13%-17.5M	-180.60%-18.8M	-273.02%-23.5M	-151.67%-45.3M	-329.41%-14.6M
Net business purchase and sale	----	----	----	--0	--0	----	----	----	-115.09%-57.2M	----
Net investment purchase and sale	-66.67%5M	-91.83%2.5M	-97.42%1.5M	320.80%105.2M	-95.86%1.5M	-48.45%15M	677.36%30.6M	266.00%58.1M	128.84%25M	260.89%36.2M
Cash from discontinued investing activities
Investing cash flow	400.00%7.5M	-154.24%-6.4M	-120.52%-7.1M	141.16%31.9M	66.29%-12M	-121.93%-2.5M	198.33%11.8M	183.78%34.6M	-128.24%-77.5M	-37.45%-35.6M
Financing cash flow
Cash flow from continuing financing activities	-24.00%-3.1M	-93.75%2.4M	-79.59%-8.8M	2,011.25%152.9M	5,904.76%121.9M	30.56%-2.5M	1,436.00%38.4M	-2.08%-4.9M	94.69%-8M	-90.91%-2.1M
Net issuance payments of debt	0.00%-100K	-100.25%-100K	---100K	--39.8M	---100K	---100K	--40M	--0	--0	--0
Net common stock issuance	----	----	----	--117.6M	----	----	----	----	--0	----
Proceeds from stock option exercised by employees	--0	----	----	-4.76%6M	150.00%6M	--0	----	----	-93.14%6.3M	33.33%2.4M
Net other financing activities	-25.00%-3M	68.75%-500K	-77.55%-8.7M	26.57%-10.5M	64.44%-1.6M	46.67%-2.4M	-700.00%-1.6M	3.92%-4.9M	10.63%-14.3M	-55.17%-4.5M
Cash from discontinued financing activities
Financing cash flow	-24.00%-3.1M	-93.75%2.4M	-79.59%-8.8M	2,011.25%152.9M	5,904.76%121.9M	30.56%-2.5M	1,436.00%38.4M	-2.08%-4.9M	94.69%-8M	-90.91%-2.1M
Net cash flow
Beginning cash position	-10.20%101.2M	67.35%105.6M	112.20%140.9M	-74.34%66.4M	-23.22%85M	6.12%112.7M	-61.90%63.1M	-74.34%66.4M	121.20%258.8M	-62.50%110.7M
Current changes in cash	127.31%7.4M	-107.51%-3.7M	-885.71%-34.5M	138.53%73.9M	222.67%55.2M	-642.00%-27.1M	183.28%49.3M	96.22%-3.5M	-234.69%-191.8M	-23.29%-45M
Effect of exchange rate changes	300.00%1.2M	-333.33%-700K	-500.00%-800K	200.00%600K	0.00%700K	-20.00%-600K	250.00%300K	133.33%200K	0.00%-600K	600.00%700K
End cash Position	29.18%109.8M	-10.20%101.2M	67.35%105.6M	112.20%140.9M	112.20%140.9M	-23.22%85M	6.12%112.7M	-61.90%63.1M	-74.34%66.4M	-74.34%66.4M
Free cash flow	85.86%-5.6M	68.02%-6.3M	52.03%-27.2M	-21.50%-184.2M	-211.42%-68.2M	-93.17%-39.6M	65.07%-19.7M	-7.39%-56.7M	-25,366.67%-151.6M	-69.77%-21.9M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Trending US Stocks

Symbol Mini Chart % Chg

Halozyme Therapeutics

Unlock the Full List